Other
Wound
0
Pipeline Programs↗
6
Active Trials↗
3
Companies Involved↗
Wound is an early-stage landscape with 0 programs across 3 companies. The most active players are Laboratorios Ozoaqua, Imbed Biosciences, MolecuLight Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
21
clinical trials
Completed9 · 43%
Unknown status4 · 19%
Not yet recruiting4 · 19%
Terminated2 · 10%
Recruiting1 · 5%
Enrolling by invitation1 · 5%
Clinical Trials
Trial Activity
21 trials
A Single Center Trial of Donor Site Wound Dressings After Split Thickness Skin Grafting.
Completed·—·Phase 4·NCT06044519·90 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)